Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
767.76
+10.22 (1.35%)
Dec 20, 2024, 4:00 PM EST - Market closed
Eli Lilly Revenue by Segment
History
| Date | Diabetes | Oncology | Immunology | Neuroscience | Other |
|---|---|---|---|---|---|
| Sep 30, 2024 | 26.16B | 8.08B | 4.21B | 1.44B | 968.50M |
| Jun 30, 2024 | 23.47B | 7.60B | 4.01B | 2.86B | 981.80M |
| Mar 31, 2024 | 20.97B | 7.11B | 3.85B | 2.91B | 1.09B |
| Dec 31, 2023 | 19.67B | 6.66B | 3.80B | 2.88B | 1.12B |
| Sep 30, 2023 | 17.90B | 6.43B | 3.63B | 2.90B | 1.22B |
| Jun 30, 2023 | 16.84B | 5.97B | 3.51B | 1.51B | 1.69B |
| Mar 31, 2023 | 15.27B | 5.67B | 3.37B | 1.51B | 1.87B |
| Dec 31, 2022 | 14.46B | 5.67B | 3.34B | 1.55B | 3.52B |
| Sep 30, 2022 | 14.12B | 5.42B | 3.37B | 1.63B | 4.70B |
| Jun 30, 2022 | 13.73B | 5.54B | 3.51B | 1.71B | 4.59B |
| Mar 31, 2022 | 13.47B | 5.72B | 3.49B | 1.83B | 4.81B |
| Dec 31, 2021 | 13.19B | 5.74B | 3.36B | 1.90B | 4.13B |
| Sep 30, 2021 | 12.86B | 5.85B | 3.10B | 1.90B | 4.04B |
| Jun 30, 2021 | 12.37B | 5.78B | 2.73B | 1.92B | 3.93B |
| Mar 31, 2021 | 11.98B | 5.49B | 2.49B | 1.83B | 3.70B |
| Dec 31, 2020 | 11.83B | 5.32B | 2.46B | 1.83B | 3.09B |
| Sep 30, 2020 | 12.06B | 5.06B | 2.31B | 1.81B | 1.97B |
| Jun 30, 2020 | 12.43B | 4.87B | 2.14B | 1.76B | 1.75B |
| Mar 31, 2020 | 12.85B | 4.80B | 2.04B | 1.79B | 1.59B |
| Dec 31, 2019 | 12.81B | 4.61B | 1.79B | 1.72B | 1.37B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.